Acute neurovascular unit protection by simvastatin in transient cerebral ischemia

被引:30
作者
Nagaraja, Tavarekere N. [1 ]
Knight, Robert A.
Croxen, Richard L.
Konda, Kirthi P.
Fenstermacher, Joseph D.
机构
[1] Henry Ford Hlth Syst, Dept Anesthesia, Detroit, MI 48202 USA
[2] Henry Ford Hlth Syst, Dept Anesthesiol, Detroit, MI 48202 USA
[3] Henry Ford Hlth Syst, Dept Neurol Res, Detroit, MI 48202 USA
[4] Michigan State Univ, Lansing, MI USA
关键词
middle cerebral artery occlusion; rat; reperfusion; stroke;
D O I
10.1179/174313206X153914
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Acute vascular-and neuroprotective effects of simvastatin were evaluated in a rat model of transient, focal cerebral ischemia. Male, Wistar rats (n = 12) underwent transient middle cerebral artery (MCA) occlusion for 3 hours followed by 3 hours of reperfusion. After 30 minutes of MCA occlusion, four rats each were subcutaneously injected with either 20 or 40 mg/kg of simvastatin. At the end of 3 hours of reperfusion, tissue injury and blood-brain barrier (BBB) opening were quantified by histology and [C-14]-alpha-aminoisobutyric acid (AIB)-based quantitative autoradiography (QAR), respectively. Compared with untreated rats, those treated with simvastatin (20 mg/kg) had reduced volumes of AIB leakage, tissue pallor and distribution space for AIB (p < 0.05). No additional effects were seen with the higher drug dose (40 mg/kg). These data suggest that the acute neuroprotective effects of statins are in part owing to attenuation of stroke-induced changes in BBB permeability.
引用
收藏
页码:826 / 830
页数:5
相关论文
共 25 条
[1]   Reperfusion injury: Demonstration of brain damage produced by reperfusion after transient focal ischemia in rats [J].
Aronowski, J ;
Strong, R ;
Grotta, JC .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1997, 17 (10) :1048-1056
[2]   Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injury [J].
Balduini, W ;
De Angelis, V ;
Mazzoni, E ;
Cimino, M .
STROKE, 2001, 32 (09) :2185-2191
[3]   Role of statins in the treatment and prevention of stroke introduction [J].
Becker, K ;
Chopp, M .
STROKE, 2004, 35 (11) :2706-2707
[4]   TRANSPORT OF ALPHA-AMINOISOBUTYRIC-ACID ACROSS BRAIN CAPILLARY AND CELLULAR MEMBRANES [J].
BLASBERG, RG ;
FENSTERMACHER, JD ;
PATLAK, CS .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1983, 3 (01) :8-32
[5]   Cholesterol reduction and stroke occurrence: An overview of randomized clinical trials [J].
Di Mascio, R ;
Marchioli, R ;
Tognoni, G .
CEREBROVASCULAR DISEASES, 2000, 10 (02) :85-92
[6]   Statins and stroke: evidence for cholesterol-independent effects [J].
Di Napoli, R ;
Taccardi, AA ;
Oliver, M ;
De Caterina, R .
EUROPEAN HEART JOURNAL, 2002, 23 (24) :1908-1921
[7]   Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase [J].
Endres, M ;
Laufs, U ;
Huang, ZH ;
Nakamura, T ;
Huang, P ;
Moskowitz, MA ;
Liao, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8880-8885
[8]   Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening [J].
Ewing, JR ;
Knight, RA ;
Nagaraja, TN ;
Yee, JS ;
Nagesh, V ;
Whitton, PA ;
Li, L ;
Fenstermacher, JD .
MAGNETIC RESONANCE IN MEDICINE, 2003, 50 (02) :283-292
[9]   Targets for vascular protection after acute ischemic stroke [J].
Fagan, SC ;
Hess, DC ;
Hohnadel, EJ ;
Pollock, DM ;
Ergul, A .
STROKE, 2004, 35 (09) :2220-2225
[10]   METHODS FOR QUANTIFYING THE TRANSPORT OF DRUGS ACROSS BRAIN BARRIER SYSTEMS [J].
FENSTERMACHER, JD ;
BLASBERG, RG ;
PLATLAK, CS .
PHARMACOLOGY & THERAPEUTICS, 1981, 14 (02) :217-248